...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Targeting Epigenetics as a New Therapy in Vascular Disease and Dementia

""the cognition or CKD sub-studies of BETonMACE.""

Which leads me to wonder.... could BETonMACE miss its endpoints, but still show significant effects on cognition?

 

Share
New Message
Please login to post a reply